G. Watanabe et al., ANGIOTENSIN-II ACTIVATION OF CYCLIN D1-DEPENDENT KINASE-ACTIVITY, The Journal of biological chemistry, 271(37), 1996, pp. 22570-22577
Angiotensin II (AII) binds to specific G protein-coupled receptors and
is mitogenic in adrenal, liver epithelial, and vascular smooth muscle
cells. Since the cyclin D1 gene encodes the regulatory subunit of the
cyclin D1-dependent kinase (CD1K) required for phosphorylation of the
retinoblastoma protein (pRB), an essential and rate-limiting step in
G(1) phase progression of the cell cycle, we examined the effect of AI
I. on cyclin D1 expression and CD1K activity in the human adrenal cell
line H295R. AII (10(-6) M) stimulated G(1) phase progression within 1
2 h, with a maximal effect after 72 h. This action was antedated by th
e induction of cyclin D1 mRNA (3-fold), cyclin D1 nuclear protein abun
dance (4-fold), and CD1K activity (4-fold). AT(1) induced cyclin D1 pr
omoter activity 4-fold, via the AT(1) receptor through an enhancer seq
uence at -954 base pairs. c-Fos and c-Jun bound the cyclin D1 -954 enh
ancer sequence, and the abundance of c-Fos within this complex was inc
reased by All treatment, AII induced extracellular signal-regulated ki
nase (ERK) activity 7-fold, and dominant-negative mutants of either p2
1(ras) or ERK reduced AII stimulated cyclin D1 promoter activity. Thes
e findings suggest that AII may stimulate mitogenesis by increasing CD
1K activity through a p21(ras)/ERK/activator protein 1 pathway.